Department of Pharmacology & Therapeutics, Faculty of Pharmacy, Kuwait University, Kuwait City, Kuwait.
Department of Anatomy, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
Respir Res. 2021 Nov 18;22(1):296. doi: 10.1186/s12931-021-01889-4.
Cough hypersensitivity is a major characteristic feature associated with several types of cough, including chronic cough, but its underlying mechanisms remain to be fully understood. Inflammatory mediators, such as prostaglandin E (PGE), have been implicated in both peripheral induction and sensitization of the cough reflex. In this study, using a conscious guinea pig model of cough, we investigated whether PGE can sensitize the cough reflex via central actions and, if so, via which mechanisms.
All drugs were administered by intracerebroventricular (i.c.v.) route and whole-body plethysmograph set-up was used for both induction, using aerosolized citric acid (0.2 M), and recording of cough. Immunohistochemistry was performed to confirm the expression of NaV 1.8 channels in the nucleus tractus solitarius (nTS).
We show that both PGE and the non-selective EP1/EP3 agonist, sulprostone, dose-dependently enhanced the citric acid-induced cough (P ≤ 0.001, P ≤ 0.01, respectively). Pretreatment with the EP1 antagonist, ONO-8130, did not affect the sulprostone-induced cough sensitization, whilst the EP3 antagonist, L-798,106, dose-dependently inhibited this effect (P ≤ 0.05). Furthermore, treatment with either the EP2 agonist, butaprost or the EP4 agonist, L-902,688, had no effect on cough sensitization. Additionally, pretreatment with either the TRPV1 antagonist, JNJ-17203212 or the TRPA1 antagonist, HC-030031, alone or in combination, nor with the NaV 1.1, 1.2, 1.3, 1.4, 1.6 and 1.7 channel blocker, tetrodotoxin, had any effect on the cough. In contrast, pretreatment with the NaV 1.8 antagonist, A-803467, dose-dependently inhibited this effect (P ≤ 0.05). Furthermore, NaV 1.8 channels were shown to be expressed in the nTS.
Collectively, our findings show that PGE sensitizes the cough reflex centrally via EP3 receptor-dependent activation of NaV 1.8 but independently of TRPV1,TRPA1 and TTX-sensitive sodium channel activation. These results indicate that PGE plays an important role in central sensitization of the cough reflex and suggest that central EP3 receptors and/or NaVv 1.8 channels may represent novel antitussive molecular targets.
咳嗽敏感性是与多种咳嗽类型相关的主要特征之一,包括慢性咳嗽,但其潜在机制仍未完全阐明。前列腺素 E (PGE) 等炎症介质已被牵涉到咳嗽反射的外周诱导和敏化中。在这项研究中,我们使用一种清醒豚鼠咳嗽模型,研究了 PGE 是否可以通过中枢作用来敏化咳嗽反射,如果可以,其机制是什么。
所有药物均通过脑室内(i.c.v.)途径给药,并用全身 plethysmograph 装置进行诱导,使用雾化柠檬酸(0.2 M),并记录咳嗽。进行免疫组织化学染色以确认钠离子通道 1.8 型 (NaV 1.8) 通道在孤束核 (nTS) 中的表达。
我们发现 PGE 和非选择性 EP1/EP3 激动剂 sulprostone 均可剂量依赖性地增强柠檬酸诱导的咳嗽(P ≤ 0.001,P ≤ 0.01)。EP1 拮抗剂 ONO-8130 预处理不影响 sulprostone 引起的咳嗽敏化,而 EP3 拮抗剂 L-798,106 则剂量依赖性地抑制了这种作用(P ≤ 0.05)。此外,EP2 激动剂 butaprost 或 EP4 激动剂 L-902,688 的治疗对咳嗽敏化没有影响。此外,TRPV1 拮抗剂 JNJ-17203212 或 TRPA1 拮抗剂 HC-030031 的单独或联合预处理,以及钠离子通道 1.1、1.2、1.3、1.4、1.6 和 1.7 通道阻滞剂河豚毒素的预处理,对咳嗽均无影响。相反,NaV 1.8 拮抗剂 A-803467 的预处理剂量依赖性地抑制了这种作用(P ≤ 0.05)。此外,NaV 1.8 通道在 nTS 中表达。
综上所述,我们的研究结果表明,PGE 通过 EP3 受体依赖性激活 NaV 1.8 来敏化咳嗽反射,中枢作用与 TRPV1、TRPA1 和 TTX 敏感的钠离子通道激活无关。这些结果表明 PGE 在咳嗽反射的中枢敏化中起重要作用,并表明中枢 EP3 受体和/或 NaVv 1.8 通道可能代表新型镇咳分子靶标。